Smoke Exposure: Clinical Trials

4 trials for Smoke Exposure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Completed 1
Phase 41Recruiting 1

Follow Smoke Exposure: new trials by email Literature Review of Smoke Exposure trials Research Report on Smoke Exposure

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Platelet-Derived Growth Factors to Enhance Healing and Reduce Post-Extraction Complications in Smokers
A- PRF - Smoke Exposure
Not applicableActive not recruitingKing Abdulaziz University122026-02-122026-08-13
Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
LAIV nasal vaccine is chosen as a model viral infection, Wood smoke, Placebo for LAIV nasal vaccine is chosen as a model viral infection - Smoke Exposure, Influenza
Phase 4RecruitingUniversity of North Carolina, Chapel Hill1122025-09-262026-04-30
Effect of Passive Smoking on Functional Capacity, Cognition and Academic Performance in Primary School Children
Smoke Exposure, Smokeless Tobacco
Not yet recruitingEgyptian Chinese University902024-12-152024-12-18
Creating Smokefree Living Together for Chinese Household Pairs
Smokefree counseling - Smoking, Smoke Exposure
Not applicableCompletedUniversity of California, Davis4102012-04-012015-06-03

Narrower conditions

Influenza, Human (1)  ·  Smoking (1)  ·  Tobacco Use (1)

Broader conditions

Behavior (2)  ·  Infections (1)  ·  Orthomyxoviridae Infections (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

FluMist (1)  ·  Influenza Vaccines (1)

Sponsors

Egyptian Chinese University (1)  ·  King Abdulaziz University (1)  ·  University of California, Davis (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (2)  ·  Saudi Arabia (1)

Top investigators

Amal G Jamjoom, MS (1)  ·  Elisa K Tong, MD, MA (1)  ·  Meghan Rebuli, PhD (1)  ·  Terry Noah, MD (1)

Results publications

PMID 34300133

NIH funding

R01ES036209 (1)